The activation of the Nrf2/ARE pathway in a transgenic familial ALS mice model demonstrated significant clinical benefits, including reduced weight decline, improved motor impairments, and prolonged survival. Here, NFE2L2 is linked to amyotrophic lateral sclerosis.